Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Xphyto Therapeutics Corp (XPHYF)

Xphyto Therapeutics Corp (XPHYF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 121,414
  • Shares Outstanding, K 64,240
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade XPHYF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6700 +13.17%
on 04/19/21
2.4117 -21.63%
on 03/22/21
-0.4918 (-20.65%)
since 03/19/21
3-Month
1.6700 +13.17%
on 04/19/21
3.1000 -39.03%
on 01/28/21
-0.4200 (-18.18%)
since 01/20/21
52-Week
1.3125 +44.00%
on 10/29/20
3.1000 -39.03%
on 01/28/21
-0.3300 (-14.86%)
since 04/06/20

Most Recent Stories

More News
XPhyto Signs German Distribution, Storage and Logistics Agreement for 25-Minute COVID-19 PCR Test

VANCOUVER, BC / ACCESSWIRE / April 21, 2021 / (CSE:XPHY / OTCQB:XPHYF / FSE:4XT) ("XPhyto" or the "Company") is pleased to announce that it has entered into an agreement (the "Agreement") with an established...

XPHY.CN : 2.370 (+2.16%)
XPHYF : 1.8900 (-0.53%)
XPhyto adds Top-Level Executive Talent to its Global Operations

VANCOUVER, BC / ACCESSWIRE / April 20, 2021 / (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to announce the appointment of Mr. Wolfgang Probst as the Chief Operations Officer...

XPHY.CN : 2.370 (+2.16%)
XPHYF : 1.8900 (-0.53%)
XPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Recent European Approval of 25-Minute COVID-19 PCR Test

via InvestorWire -- XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient...

XPHY.CN : 2.370 (+2.16%)
XPHYF : 1.8900 (-0.53%)
Proactive news headlines including Silver Range Resources, Vuzix Corp, Endeavour Mining and Delta 9 Cannabis

- Altiplano Metals closes C$3.1 million non-brokered private placement click here

SNG.VN : 0.215 (+13.16%)
VST.CN : 0.770 (-2.53%)
VSQTF : 0.6124 (-2.86%)
RDHL : 6.58 (-2.95%)
GEM : 39.99 (-0.67%)
MEEC : 0.9075 (-10.15%)
RCRT : 3.0000 (-4.76%)
VR.CN : 0.085 (unch)
VRCFF : 0.0640 (-5.19%)
ALPP : 2.5600 (-11.42%)
ORGS : 5.07 (+0.40%)
TCF.CN : 0.370 (-2.63%)
TCFF : 0.2942 (-0.81%)
AREC : 3.15 (+9.76%)
BRC : 54.95 (-0.49%)
CBDHF : 1.0800 (+0.14%)
SFET : 1.2600 (-4.55%)
NEXNF : 1.0870 (-10.17%)
MRBL.CN : 0.220 (-8.33%)
MRBLF : 0.1783 (-7.09%)
SLRRF : 0.1360 (-12.09%)
FF : 12.68 (-2.46%)
FFMGF : 0.2831 (-1.01%)
ARU : 25.20 (-0.32%)
VUZI : 20.58 (-7.09%)
EDV : 129.35 (+0.53%)
EDVMF : 22.8579 (+1.01%)
PYR.TO : 6.16 (-0.81%)
PYR : 4.92 (-1.60%)
NC.CN : 0.810 (-3.57%)
NTTCF : 0.6363 (-2.56%)
VLNCF : 2.1600 (-5.26%)
XPHY.CN : 2.370 (+2.16%)
XPHYF : 1.8900 (-0.53%)
CANN.CN : 0.120 (unch)
HERTF : 0.0995 (-2.45%)
MTRX : 12.36 (-4.48%)
RACMF : 1.0788 (-3.06%)
DN.TO : 0.57 (unch)
DLTNF : 0.4570 (+0.44%)
PRSRF : 0.3184 (+1.27%)
XPhyto announces European Approval for 25 Minute COVID-19 PCR Test

CE Mark received for in vitro diagnostic (IVD) test for the detection of SARS-CoV-2Rapid results with ease of use - single 20-minute PCR cycle plus 5-minute detection processHigh sensitivity - 104.73 c/PCR...

XPHY.CN : 2.370 (+2.16%)
XPHYF : 1.8900 (-0.53%)
InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp.

via InvestorWire -- InvestorBrandNetwork ("IBN"), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the...

XPHY.CN : 2.370 (+2.16%)
XPHYF : 1.8900 (-0.53%)
XPhyto Partner Receives ISO Certification for 25-Minute COVID-19 RT-PCR Test

VANCOUVER, BC / ACCESSWIRE / March 10, 2021 / (CSE:XPHY / OTCQB:XPHYF / FSE:4XT) ("XPhyto" or the "Company"), and its exclusive German diagnostics development partner, 3a-diagnostics GmbH ("3a"), are...

XPHY.CN : 2.370 (+2.16%)
XPHYF : 1.8900 (-0.53%)
Emerging Markets Report: A Psychedelic Story

An Emerging Markets Sponsored Commentary

XPHYF : 1.8900 (-0.53%)
XPhyto Completes Corporate Rebranding and Launches New Website

VANCOUVER, BC / ACCESSWIRE / March 4, 2021 / (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company"), is pleased to announce that the Company has completed a corporate rebranding and launched a new...

XPHY.CN : 2.370 (+2.16%)
XPHYF : 1.8900 (-0.53%)
With Psilocybin, Significant Progress is Being Made with Substance Use Disorders

Mental health support is not as strong as it should be for Canadians. At the moment, an overburdened ...

NUMI.VN : 0.830 (-7.78%)
LKYSF : 0.6500 (-9.47%)
MCUR.CN : 0.335 (-8.22%)
MCURF : 0.2690 (-6.27%)
SEEL : 5.10 (+2.00%)
XPHYF : 1.8900 (-0.53%)
XPHY.CN : 2.370 (+2.16%)
MSET.CN : 0.510 (+10.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 2.1199
2nd Resistance Point 2.0362
1st Resistance Point 1.9631
Last Price 1.8900
1st Support Level 1.8063
2nd Support Level 1.7226
3rd Support Level 1.6495

See More

52-Week High 3.1000
Fibonacci 61.8% 2.4172
Fibonacci 50% 2.2062
Fibonacci 38.2% 1.9953
Last Price 1.8900
52-Week Low 1.3125

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar